Why the study?
Does chlorthalidone improve therapeutic success and reduce blood pressure safely in patients 60 years of age or older with isolated systolic hypertension?
Does chlorthalidone improve therapeutic success and reduce blood pressure safely in patients 60 years of age or older with isolated systolic hypertension?
Low-dose chlorthalidone (12.5 mg/day) provides effective and safe treatment for isolated systolic hypertension in the elderly, avoiding the increased side effects seen at higher doses.
Answers are grounded in this paper and cite their sources.
Low-dose chlorthalidone safely controls isolated systolic hypertension in older adults; confirms optimal dosing with minimal side effects versus higher doses.
One hundred seventy-one patients, 60 years of age or older with isolated systolic hypertension, were randomly assigned to receive chlorthalidone 12.5, 25.0, or 50.0 mg or placebo once daily for 12 weeks. The majority of the patients receiving chlorthalidone 12.5 mg achieved therapeutic success with no clinically significant biochemical changes or side effects. The 50.0-mg dose level enhanced efficacy only minimally over the 25.0-mg dose level. Drug-related side effects were significantly more prevalent in the chlorthalidone 50.0-mg group than in the placebo group. The data suggest that most elderly patients with isolated systolic hypertension, regardless of the severity, could be treated effectively and safely with chlorthalidone 12.5 mg per day.
No takes yet. Share an insight, caveat, or question.
Morledge et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: